Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsGudbjartsson, Daniel F
Norddahl, Gudmundur L
Eggertsson, Hannes P
Indridason, Olafur S
Eyjolfsson, Gudmundur I
Matthiasson, Stefan E
Halldorsson, Bjarni V
Hreidarsson, Astradur B
Valdimarsson, Einar M
MetadataShow full item record
CitationGudbjartsson DF, Thorgeirsson G, Sulem P, et al. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes. J Am Coll Cardiol. 2019;74(24):2982–2994. doi:10.1016/j.jacc.2019.10.019
AbstractBackground: Lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular diseases that has no established therapy. The attribute of Lp(a) that affects cardiovascular risk is not established. Low levels of Lp(a) have been associated with type 2 diabetes (T2D). Objectives: This study investigated whether cardiovascular risk is conferred by Lp(a) molar concentration or apolipoprotein(a) [apo(a)] size, and whether the relationship between Lp(a) and T2D risk is causal. Methods: This was a case-control study of 143,087 Icelanders with genetic information, including 17,715 with coronary artery disease (CAD) and 8,734 with T2D. This study used measured and genetically imputed Lp(a) molar concentration, kringle IV type 2 (KIV-2) repeats (which determine apo(a) size), and a splice variant in LPA associated with small apo(a) but low Lp(a) molar concentration to disentangle the relationship between Lp(a) and cardiovascular risk. Loss-of-function homozygotes and other subjects genetically predicted to have low Lp(a) levels were evaluated to assess the relationship between Lp(a) and T2D. Results: Lp(a) molar concentration was associated dose-dependently with CAD risk, peripheral artery disease, aortic valve stenosis, heart failure, and lifespan. Lp(a) molar concentration fully explained the Lp(a) association with CAD, and there was no residual association with apo(a) size. Homozygous carriers of loss-of-function mutations had little or no Lp(a) and increased the risk of T2D. Conclusions: Molar concentration is the attribute of Lp(a) that affects risk of cardiovascular diseases. Low Lp(a) concentration (bottom 10%) increases T2D risk. Pharmacologic reduction of Lp(a) concentration in the 20% of individuals with the greatest concentration down to the population median is predicted to decrease CAD risk without increasing T2D risk. Keywords: Lp(a); Mendelian randomization; coronary artery disease; genetics; type 2 diabetes.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
RightsCopyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
- Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
- Authors: Ooi EM, Ellis KL, Barrett PHR, Watts GF, Hung J, Beilby JP, Thompson PL, Stobie P, McQuillan BM
- Issue date: 2018 Aug
- <i>LPA</i> kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk.
- Authors: Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL, Zhai 翟天羽 TY, Ling 凌雁 Y, Gao 高鑫 X
- Issue date: 2018 May
- Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
- Authors: Sun L, Zong M, Chen C, Xie L, Wu F, Yu M, Fan L
- Issue date: 2018 May 10
- A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
- Authors: Coassin S, Erhart G, Weissensteiner H, Eca Guimarães de Araújo M, Lamina C, Schönherr S, Forer L, Haun M, Losso JL, Köttgen A, Schmidt K, Utermann G, Peters A, Gieger C, Strauch K, Finkenstedt A, Bale R, Zoller H, Paulweber B, Eckardt KU, Hüttenhofer A, Huber LA, Kronenberg F
- Issue date: 2017 Jun 14
- Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.
- Authors: Gambhir JK, Kaur H, Prabhu KM, Morrisett JD, Gambhir DS
- Issue date: 2008 May